Stay updated on Mepolizumab in Severe Asthma: Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.

Latest updates to the Mepolizumab in Severe Asthma: Clinical Trial page
- Check7 days agoChange DetectedRevision updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a comprehensive Locations section listing multiple Chinese regions (Fujian, Guangdong, Guizhou, Hebei, Henan, Hubei, Hunan, Inner Mongolia, Jiangsu, Jilin, Liaoning, Ningxia, Shandong, Shanxi, Sichuan, Xinjiang, Zhejiang) and the Revision: v3.3.3; removed individual per-location entries to reorganize the site listings.SummaryDifference1%

- Check58 days agoChange DetectedPublications section wording updated to indicate that PubMed-derived publications are automatically populated, and the revision number changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe government funding status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check87 days agoChange DetectedThe two screenshots show the same Study Details page for NCT03562195 with identical sections and content.SummaryDifference0.3%

- Check108 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%

Stay in the know with updates to Mepolizumab in Severe Asthma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Severe Asthma: Clinical Trial page.